Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: gsk
gsk
Update Il y a 5 ans
Evaluation of the safety and immunogenicity of a Hepatitis A Vaccine in Patients with Chronic Viral Hepatitis B and C and chronic liver disease of other etiology
Country
None
organs
None
Specialty
None
Closed trial
More information
gsk
Update Il y a 5 ans
A 12-Week, Multicenter, Double-Blind, Placebo-Controlled, Dose Response Study Assessing the Safety, Tolerability, and Efficacy of BRL 49653C in Subjects with Non-Insulin Dependent Diabetes Mellitus (NIDDM)
Country
None
organs
None
Specialty
None
Closed trial
More information
gsk
Update Il y a 5 ans
Drug Use Investigation for Imigran injection
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman Max 99 years
gsk
Update Il y a 5 ans
Skin Acceptability Assessment of the cosmetic product SM Translucent, in subjects with all Skin Types Under Normal Usage Conditions
This will be a open label and non-comparative study. The purpose of this clinical trial is to evaluate the acceptability of the cosmetic product in study in research subjects with all skin types by ev...
Country
None
organs
None
Specialty
None
Closed trial
More information
gsk
Update Il y a 5 ans
An Open Phase II Study to Evaluate the Efficacy and Toxicity of Topotecan Administered Intravenously as Five Daily Infusions Every 21 Days to Patients with Advanced Non-Small Cell Lung Cancer
Country
None
organs
None
Specialty
None
Closed trial
More information
gsk
Update Il y a 5 ans
A double blind, randomized, controlled, dose ranging study of Org31540/SR90107A in patients with unstable angina pectoris: PENTUA
Country
None
organs
None
Specialty
None
Closed trial
More information
gsk
Update Il y a 5 ans
A Double-Blind, Placebo-Controlled Study of Paroxetine in Depressed Outpatients
Country
None
organs
None
Specialty
None
Closed trial
More information
gsk
Update Il y a 6 ans
Clinical Evaluation of BRL49653C twice daily in Type-2 Diabetes Mellitus (Combination therapy) – Double-blind, dose-finding study
Country
None
organs
None
Specialty
None
Closed trial
More information
gsk
Update Il y a 5 ans
A Single-Center, Evaluator-Blinded, Randomized, Placebo-Controlled, Phase 1 Clinical Trial Evaluating the Potential of Topically Applied EF Calcipotriene Foam, 0.005% to Induce Contact Sensitization in Healthy Volunteers Upon Exposure to Repeated Skin Patch Applications
Country
None
organs
None
Specialty
None
Closed trial
More information
gsk
Update Il y a 6 ans
The metabolic syndrome in the DAD Study
Country
None
organs
None
Specialty
None
Closed trial
More information
Previous
1
2
3
4
5
6
7
8
9
10
Next